All articles tagged with #virology
The CDC says the BA.3.2 COVID variant, descended from Omicron, has been detected in 25 U.S. states (via nasal swabs and wastewater) and was first identified in travelers, but it is not the dominant strain and does not appear to cause a different illness; current vaccines target other Omicron subvariants, so protection may be incomplete.
A case study reports progressive multifocal leukoencephalopathy (PML) caused by JC virus activation in a 72-year-old patient with stage-5 CKD, suggesting CKD can create noncanonical immunosuppression that predisposes to JC virus–related brain damage. The JC virus is common and usually latent but can reactivate to destroy brain myelin, diagnosed by MRI lesions and JC virus DNA in CSF; the patient died two days after diagnosis, highlighting the seriousness of PML in CKD as CKD prevalence rises.
A UC San Diego‑led genomic analysis of Ebola, Marburg, mpox, influenza A, and SARS‑CoV‑2 finds no evidence that most pandemic viruses required adaptation in an animal reservoir or in a lab before infecting humans; selection changes usually appear after human transmission. The study does note a possible lab‑linked signal for the 1977 H1N1 influenza and cites palm civet–associated SARS‑CoV as a historical example, but argues SARS‑CoV‑2 likely arose through natural zoonotic transmission. The authors stress that distinguishing natural spillovers from lab mishandling relies on genomic signals and call for strengthened surveillance and spillover prevention to prepare for future pandemics, challenging theories that COVID‑19 was lab‑engineered.
UC San Diego researchers analyzed genomes from influenza A, Ebola, Marburg, mpox, SARS-CoV and SARS-CoV-2 and found that most zoonotic viruses do not show adaptive evolution before jumping to humans; SARS-CoV-2 shows no lab-adaptation signal, consistent with natural spillover, while the 1977 H1N1 pandemic shows lab-adaptation signatures—together providing a framework to distinguish natural outbreaks from laboratory manipulation and guiding future outbreak surveillance.
A virologist and home brewer, Chris Buck, claims to have created the world's first beer-based vaccine using genetically modified yeast, which he believes can immunize against certain viruses and potentially be used for other diseases like COVID-19 and flu. Despite concerns from the scientific community about safety and public trust, Buck has already brewed and tested his vaccine beer on himself, showing promising antibody responses, and aims to develop it further for broader use.
David Baltimore, a pioneering virologist whose discovery of reverse transcriptase revolutionized understanding of retroviruses and contributed significantly to cancer and HIV/AIDS research, has passed away at age 87. His work challenged the central dogma of molecular biology and provided essential tools for modern genetic research.
David Baltimore, a Nobel Prize-winning virologist, former Caltech president, and influential scientist known for discovering reverse transcriptase, passed away at age 87. His groundbreaking work in molecular biology, immunology, and science policy significantly advanced medicine and biotechnology. Baltimore's leadership at Caltech and contributions to global health and science policy left a lasting legacy. He is survived by his wife Alice Huang and daughter TK Baltimore.
David Baltimore, a Nobel laureate and former Caltech president renowned for his groundbreaking work in virology and genetic engineering, passed away at 87. His career was marked by significant scientific discoveries, leadership in bioethics, and influential roles in academia and industry, leaving a lasting legacy in biology and medicine.
The Democratic Republic of the Congo has declared its 16th Ebola outbreak, with genomic analysis indicating a new spillover event from an unknown reservoir, distinct from previous outbreaks, confirmed through rapid sequencing and phylogenetic analysis.
Despite a significant increase in human H5N1 bird flu cases in the U.S., all have been mild, puzzling scientists given the virus's historically high fatality rate. Researchers are exploring various hypotheses, including the mode of transmission, the specific virus strain, and potential pre-existing immunity from exposure to similar viruses. The mildness of U.S. cases contrasts with more severe cases in Asia, raising questions about the virus's true pathogenicity and the accuracy of previous fatality estimates.
Beata Halassy, a virologist from the University of Zagreb, successfully treated her recurring breast cancer by experimenting on herself with virus-based therapies, which are being researched globally as alternatives to conventional treatments like chemotherapy.
Croatian virologist Beata Halassy successfully treated her own breast cancer using lab-grown viruses, avoiding chemotherapy. Her self-administered oncolytic virotherapy, involving measles and vesicular stomatitis viruses, led to a significant tumor reduction and a four-year cancer-free period. While her case highlights the potential of oncolytic virotherapy, it raises ethical concerns about self-experimentation and the risk of encouraging unproven treatments. Despite initial journal rejections due to ethical issues, Halassy published her findings to contribute to scientific knowledge.
Dr. Beata Halassy, an infectious disease researcher, successfully treated her stage 3 breast cancer using a self-developed experimental vaccine combining measles and flu-like viruses. This oncolytic virotherapy approach shrank the tumor, allowing for easier surgical removal, and has kept her in remission for four years. While her results, published in the journal Vaccines, show promise, they raise ethical concerns about self-experimentation and potential risks for others attempting similar treatments without medical oversight.
Recent research has revealed that viruses have a complex social life, engaging in behaviors such as cheating and cooperation within cells and hosts. Sociovirologists believe that viruses make sense only as members of a community, and studies have shown that incomplete viruses, previously thought to be lab artifacts, are actually abundant inside our bodies. These incomplete viruses, also known as cheaters, exploit the cooperation of other viruses to replicate, but some researchers believe they may also play a more benign role in viral societies. Understanding the social behavior of viruses could potentially be exploited to develop new antiviral strategies, although caution is advised due to the living and evolving nature of viruses.
New research suggests that antibiotics can effectively target gut bacteria that harbor the virus causing COVID-19, potentially reducing COVID-19-related symptoms and aiding in faster recovery. A study involving 211 participants found that early antibiotic treatment, specifically a combination of amoxicillin and rifaximin within the first 3 days of infection, led to quicker recovery and a lower incidence of long COVID. These findings may influence future vaccine strategies and the treatment of acute COVID-19 infections.